News
Grants
Dr. Cui received multiple grants this year:
§R01: Targeting PGC-1a for the treatment of sickle cell disease (2022-25)
§GBT Therapeutics: In vivo evaluation of GBT compounds in a mouse model (2022-23)
§Doris Duke Advancing Cures Award (Renewal): Modulation of LSD1 and PGC-1a using small molecule inhibitors to induce fetal hemoglobin (2023-25)
Cheers!
Grant
Dr. Cui received a supplemental grant from Doris Duke Charitable Foundation for sickle cell disease research.
Nicole and Nika
Congratulations! Nicole Nguyen and Nika Kozlov both received the Summer 2021 UROP Awards.
Nicole's project focused on determining optimal conditions of DMNT1 Inhibitor, decitabine, to induce maximal fetal hemoglobin expression in human erythroid progenitor cells.
Nika's project focused on evaluating the in vivo effects of PGC-1a agonists, ZLN005 and SR-18292, in sickle cell disease mice.
Kate
Jan 6th, 2021 Congratulations to Kate, her UROP Student Research Award has been approved for funding.
Her project focused on LSD1 inhibition for fetal hemoglobin induction.